Lifeward Ltd.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
PART IFINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS LIFEWARD LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | ||
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $5,728 | $6,746 |
| Restricted Cash | 194 | 197 |
| Trade receivables, net of credit losses of $216 and $160, respectively | 5,165 | 6,004 |
| Prepaid expenses and other current assets | 1,929 | 1,624 |
| Inventories | 6,802 | 6,723 |
| Total current assets | 19,818 | 21,294 |
| LONG-TERM ASSETS | ||
| Restricted cash and other long-term assets | 219 | 240 |
| Operating lease right-of-use assets | 457 | 548 |
| Property and equipment, net | 777 | 867 |
| Goodwill | 7,538 | 7,538 |
| Total long-term assets | 8,991 | 9,193 |
| Total assets | $28,809 | $30,487 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
LIFEWARD LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | ||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Trade payables | $4,466 | $5,022 |
| Employees and payroll accruals | 1,174 | 1,332 |
| Deferred revenues | 1,327 | 1,248 |
| Current maturities of operating leases liability | 571 | 858 |
| Earnout liability | 608 | 608 |
| Other current liabilities | 925 | 1,157 |
| Total current liabilities | 9,071 | 10,225 |
| LONG-TERM LIABILITIES | ||
| Deferred revenues | 1,173 | 1,324 |
| Non-current operating leases liability | 48 | 22 |
| Other long-term liabilities | 61 | 67 |
| Total long-term liabilities | 1,282 | 1,413 |
| Total liabilities | 10,353 | 11,638 |
| COMMITMENTS AND CONTINGENT LIABILITIES | ||
| Shareholders’ equity: | ||
| Share capital | ||
| Ordinary share of NIS 1.75 par value-Authorized: 25,000,000 shares at March 31, 2025 and December 31, 2024; Issued: 11,204,939 and 9,382,801 shares at March 31, 2025 and December 31, 2024, respectively; Outstanding: 10,630,281 and 8,808,143 shares as of March 31, 2025 and December 31, 2024 respectively | 5,461 | 4,590 |
| Additional paid-in capital | 285,857 | 282,287 |
| Treasury Shares at cost, 574,658 ordinary shares at March 31, 2025 and December 31, 2024 | (3,203) | (3,203) |
| Accumulated deficit | (269,659) | (264,825) |
| Total shareholders’ equity | 18,456 | 18,849 |
| Total liabilities and shareholders’ equity | $28,809 | $30,487 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.